


<PubmedArticle>
    <MedlineCitation Status="In-Process" Owner="NLM">
        <PMID Version="1">31198791</PMID>
        <DateRevised>
            <Year>2019</Year>
            <Month>06</Month>
            <Day>14</Day>
        </DateRevised>
        <Article PubModel="Electronic-eCollection">
            <Journal>
                <ISSN IssnType="Electronic">2314-7156</ISSN>
                <JournalIssue CitedMedium="Internet">
                    <Volume>2019</Volume>
                    <PubDate>
                        <Year>2019</Year>
                    </PubDate>
                </JournalIssue>
                <Title>Journal of immunology research</Title>
                <ISOAbbreviation>J Immunol Res</ISOAbbreviation>
            </Journal>
            <ArticleTitle>Cervical Cancer Cells Express Markers Associated with Immunosurveillance.</ArticleTitle>
            <Pagination>
                <MedlinePgn>1242979</MedlinePgn>
            </Pagination>
            <ELocationID EIdType="doi" ValidYN="Y">10.1155/2019/1242979</ELocationID>
            <Abstract>
                <AbstractText>Cervical cancer is the second most frequent cancer in women in Mexico, and its development depends on the presence of human papillomaviruses in the uterine cervix. These oncogenic viruses transform cells where the control over cell cycle disappears, and the capacity to induce apoptosis is absent. On the other hand, some mutations confer to the transformed cells the ability to evade recognition by the immune system. The expression of markers of the immune system such as CD95, MICA/B, CD39, CD73, NKp30, NKp46, CD44, CD24, NKG2A, and CTLA-4 was analysed by flow cytometry on cervical cancer cells INBL (HPV 18, stage IVB), HeLa (HPV 18), CaSki (HPV 16), and C33A (HPV-). Our results showed the presence of atypical markers on cervical cancer cells; some of them are molecules involved in tumour cell recognition such as MICA/B and CD95. Other markers associated with immune system escape, such as CD39, CD73, and CTLA-4, were also present. Furthermore, we found that some cervical cancer cells expressed typical markers of NK cells like NKp30, NKp46, NKG2A, and KIR3DL1. It is not clear whether these molecules confer any gain to the tumour cells or if they represent a disadvantage, but we hypothesise that these molecules that are present in cervical cancer cells allow them to mimic in front of the immune system.</AbstractText>
            </Abstract>
            <AuthorList CompleteYN="Y">
                <Author ValidYN="Y">
                    <LastName>Gutiérrez-Hoya</LastName>
                    <ForeName>Adriana</ForeName>
                    <Initials>A</Initials>
                    <AffiliationInfo>
                        <Affiliation>Laboratorio de Oncología Molecular, FES Zaragoza, Universidad Nacional Autónoma de México, Batalla 5 de mayo s/n Col. Ejército de Oriente, CP 09230 Ciudad de México, Mexico.</Affiliation>
                    </AffiliationInfo>
                    <AffiliationInfo>
                        <Affiliation>Cátedras CONACyT, CONACYT, Avenida Insurgentes Sur 1582, Benito Juárez, Crédito Constructor, 03940 Ciudad de México, Mexico.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Zerecero-Carreón</LastName>
                    <ForeName>Octavio</ForeName>
                    <Initials>O</Initials>
                    <AffiliationInfo>
                        <Affiliation>Laboratorio de Oncología Molecular, FES Zaragoza, Universidad Nacional Autónoma de México, Batalla 5 de mayo s/n Col. Ejército de Oriente, CP 09230 Ciudad de México, Mexico.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Valle-Mendiola</LastName>
                    <ForeName>Arturo</ForeName>
                    <Initials>A</Initials>
                    <Identifier Source="ORCID">0000-0001-6782-4547</Identifier>
                    <AffiliationInfo>
                        <Affiliation>Laboratorio de Oncología Molecular, FES Zaragoza, Universidad Nacional Autónoma de México, Batalla 5 de mayo s/n Col. Ejército de Oriente, CP 09230 Ciudad de México, Mexico.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Moreno-Lafont</LastName>
                    <ForeName>Martha</ForeName>
                    <Initials>M</Initials>
                    <AffiliationInfo>
                        <Affiliation>Departamento de Inmunología, Escuela Nacional de Ciencias Biológicas, Instituto Politécnico Nacional, Prolongación de Carpio y Plan de Ayala S/N. Colonia Santos Tomás, Miguel Hidalgo, 11340 Ciudad de México, Mexico.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>López-Santiago</LastName>
                    <ForeName>Rubén</ForeName>
                    <Initials>R</Initials>
                    <Identifier Source="ORCID">0000-0003-3629-3813</Identifier>
                    <AffiliationInfo>
                        <Affiliation>Departamento de Inmunología, Escuela Nacional de Ciencias Biológicas, Instituto Politécnico Nacional, Prolongación de Carpio y Plan de Ayala S/N. Colonia Santos Tomás, Miguel Hidalgo, 11340 Ciudad de México, Mexico.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Weiss-Steider</LastName>
                    <ForeName>Benny</ForeName>
                    <Initials>B</Initials>
                    <AffiliationInfo>
                        <Affiliation>Laboratorio de Oncología Molecular, FES Zaragoza, Universidad Nacional Autónoma de México, Batalla 5 de mayo s/n Col. Ejército de Oriente, CP 09230 Ciudad de México, Mexico.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Soto-Cruz</LastName>
                    <ForeName>Isabel</ForeName>
                    <Initials>I</Initials>
                    <Identifier Source="ORCID">0000-0001-5115-3654</Identifier>
                    <AffiliationInfo>
                        <Affiliation>Laboratorio de Oncología Molecular, FES Zaragoza, Universidad Nacional Autónoma de México, Batalla 5 de mayo s/n Col. Ejército de Oriente, CP 09230 Ciudad de México, Mexico.</Affiliation>
                    </AffiliationInfo>
                </Author>
            </AuthorList>
            <Language>eng</Language>
            <PublicationTypeList>
                <PublicationType UI="D016428">Journal Article</PublicationType>
            </PublicationTypeList>
            <ArticleDate DateType="Electronic">
                <Year>2019</Year>
                <Month>05</Month>
                <Day>06</Day>
            </ArticleDate>
        </Article>
        <MedlineJournalInfo>
            <Country>Egypt</Country>
            <MedlineTA>J Immunol Res</MedlineTA>
            <NlmUniqueID>101627166</NlmUniqueID>
            <ISSNLinking>2314-7156</ISSNLinking>
        </MedlineJournalInfo>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="received">
                <Year>2018</Year>
                <Month>08</Month>
                <Day>04</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="revised">
                <Year>2018</Year>
                <Month>11</Month>
                <Day>03</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="accepted">
                <Year>2019</Year>
                <Month>03</Month>
                <Day>18</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="entrez">
                <Year>2019</Year>
                <Month>6</Month>
                <Day>15</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2019</Year>
                <Month>6</Month>
                <Day>15</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2019</Year>
                <Month>6</Month>
                <Day>15</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>epublish</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="pubmed">31198791</ArticleId>
            <ArticleId IdType="doi">10.1155/2019/1242979</ArticleId>
            <ArticleId IdType="pmc">PMC6526527</ArticleId>
        </ArticleIdList>
    </PubmedData>
</PubmedArticle>

